[1]
W. Phadungvorasart and K. Kulkantrakorn, “Janus kinase 1/2 inhibition with Baricitinib for treatment of anti-signal recognition particle necrotizing autoimmune myositis: a case report”, BKK Med J, vol. 19, no. 2, p. 121, Sep. 2023.